2010
DOI: 10.1007/s00167-010-1238-6
|View full text |Cite
|
Sign up to set email alerts
|

Platelet-rich plasma intra-articular knee injections for the treatment of degenerative cartilage lesions and osteoarthritis

Abstract: These findings indicate that treatment with PRP injections can reduce pain and improve knee function and quality of life with short-term efficacy. Further studies are needed to confirm these results and understand the mechanism of action, and to find other application modalities, with different platelet and GF concentrations and injection timing, which provide better and more durable results.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

32
311
7
17

Year Published

2012
2012
2024
2024

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 391 publications
(367 citation statements)
references
References 29 publications
32
311
7
17
Order By: Relevance
“…The intra-articular injection of MSCs, autologous PL and dexamethasone in a human patient with osteoarthritis of the knee resulted in a significant decrease in cartilage defect size (Centeno et al 2008). Furthermore, in human patients with knee osteoarthritis, the use of intra-articular injections of various platelet-rich preparations as sources of growth factors resulted in significant clinical improvement and pain reduction up to 6 or 12 months post-treatment (Kon et al 2010;Filardo et al 2011). Similar results were reported when such treatment was compared with hyalunoral (S anchez et al 2008) or normal saline injections (Patel et al 2013).…”
Section: Discussionmentioning
confidence: 99%
“…The intra-articular injection of MSCs, autologous PL and dexamethasone in a human patient with osteoarthritis of the knee resulted in a significant decrease in cartilage defect size (Centeno et al 2008). Furthermore, in human patients with knee osteoarthritis, the use of intra-articular injections of various platelet-rich preparations as sources of growth factors resulted in significant clinical improvement and pain reduction up to 6 or 12 months post-treatment (Kon et al 2010;Filardo et al 2011). Similar results were reported when such treatment was compared with hyalunoral (S anchez et al 2008) or normal saline injections (Patel et al 2013).…”
Section: Discussionmentioning
confidence: 99%
“…There is an increased use of platelet related products for the treatment of knee OA in human beings (Kon et al 2009, Filardo et al 2011. Platelet concentrates have also been used for the treatment of OA and OC in horses (Carmona et al 2009).…”
Section: Resultsmentioning
confidence: 99%
“…APC have been widely used in human and veterinary procedures. Recent results have shown that APC can be used safely to treat OA in horses (Carmona et al 2009) and human beings (Kon et al 2009, Filardo et al 2011. Further, recently was described the use of autologous conditioned plasma (a kind of PRP)…”
Section: Introductionmentioning
confidence: 99%
“…16 Filardo et al reported that 3 injections of intra-articular PRP in 90 patients with chronic knee degenerative conditions revealed improvement in International Knee Documentation Committee (IKDC) and EQ-VAS scores at the 2-year follow-up and that it had discernible positive effects especially on younger patients with early osteoarthritis. 17 However which growth factors are more beneficial needs better understanding. Since there is a lack of research evidence on treatment and efficacy of PRP injection, preparation methods, site of injection, and dose for clinical efficacy needs to be determined.…”
Section: Discussionmentioning
confidence: 99%